These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 17939062)
1. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Geary J; Sasieni P; Houlston R; Izatt L; Eeles R; Payne SJ; Fisher S; Hodgson SV Fam Cancer; 2008; 7(2):163-72. PubMed ID: 17939062 [TBL] [Abstract][Full Text] [Related]
2. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016 [TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581 [TBL] [Abstract][Full Text] [Related]
4. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene. Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003 [TBL] [Abstract][Full Text] [Related]
5. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610 [TBL] [Abstract][Full Text] [Related]
6. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies. Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289 [TBL] [Abstract][Full Text] [Related]
7. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. Wagner A; Hendriks Y; Meijers-Heijboer EJ; de Leeuw WJ; Morreau H; Hofstra R; Tops C; Bik E; Bröcker-Vriends AH; van Der Meer C; Lindhout D; Vasen HF; Breuning MH; Cornelisse CJ; van Krimpen C; Niermeijer MF; Zwinderman AH; Wijnen J; Fodde R J Med Genet; 2001 May; 38(5):318-22. PubMed ID: 11333868 [TBL] [Abstract][Full Text] [Related]
8. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome. Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915 [TBL] [Abstract][Full Text] [Related]
9. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. Win AK; Lindor NM; Winship I; Tucker KM; Buchanan DD; Young JP; Rosty C; Leggett B; Giles GG; Goldblatt J; Macrae FA; Parry S; Kalady MF; Baron JA; Ahnen DJ; Marchand LL; Gallinger S; Haile RW; Newcomb PA; Hopper JL; Jenkins MA J Natl Cancer Inst; 2013 Feb; 105(4):274-9. PubMed ID: 23385444 [TBL] [Abstract][Full Text] [Related]
10. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome. Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ; Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173 [TBL] [Abstract][Full Text] [Related]
11. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia. Irmejs A; Borosenko V; Melbarde-Gorkusa I; Gardovskis A; Bitina M; Kurzawski G; Suchy J; Gorski B; Gardovskis J Anticancer Res; 2007; 27(1B):653-8. PubMed ID: 17348456 [TBL] [Abstract][Full Text] [Related]
12. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families. Boilesen AE; Bisgaard ML; Bernstein I Acta Obstet Gynecol Scand; 2008; 87(11):1129-35. PubMed ID: 18972272 [TBL] [Abstract][Full Text] [Related]
13. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. Lin KM; Shashidharan M; Thorson AG; Ternent CA; Blatchford GJ; Christensen MA; Watson P; Lemon SJ; Franklin B; Karr B; Lynch J; Lynch HT J Gastrointest Surg; 1998; 2(1):67-71. PubMed ID: 9841970 [TBL] [Abstract][Full Text] [Related]
14. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044 [TBL] [Abstract][Full Text] [Related]
15. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families. Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866 [TBL] [Abstract][Full Text] [Related]
16. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847 [TBL] [Abstract][Full Text] [Related]
18. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128 [TBL] [Abstract][Full Text] [Related]
19. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E Digestion; 2004; 69(3):166-76. PubMed ID: 15118395 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]